PT  - JOURNAL ARTICLE
AU  - Christopher M. Saliba
AU  - Michael J. Rainbow
AU  - W. Scott Selbie
AU  - Kevin J. Deluzio
AU  - Stephen H. Scott
TI  - Co-contraction uses dual control of agonist-antagonist muscles to improve motor performance
AID  - 10.1101/2020.03.16.993527
DP  - 2020 Jan 01
TA  - bioRxiv
PG  - 2020.03.16.993527
4099  - http://biorxiv.org/content/early/2020/03/18/2020.03.16.993527.short
4100  - http://biorxiv.org/content/early/2020/03/18/2020.03.16.993527.full
AB  - Co-contraction of agonist-antagonist muscles is commonly observed when performing difficult motor tasks. The benefit of co-contraction is thought to be zero-delay corrections to unexpected disturbances from increased intrinsic muscle impedance. We used upper-limb postural and tracking tasks to characterize the effects of co-contraction on motor corrections to loads applied to the limb. We systematically controlled pre-perturbation muscle activity and showed that co-contraction improves subsequent corrective responses in both tasks. However, substantial improvements in the corrective response are only observed at the time when neural feedback pathways can also contribute. We demonstrate that muscle impedance appears to play a minor role in improving performance. Instead, co-contraction engages a dual agonist-antagonist control strategy to counter disturbances, that is distinct from the control strategy used when not co-contracting or selectively pre-activating a single muscle group. Critically, we showed that this dual agonist-antagonist control strategy improved performance even at low levels of co-contraction.